Phocas Financial Corp.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1356783 ALAMEDA, CA

Position in SUPN

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$2,802,367

-$475,450 QoQ

Shares Held

60,253

-5.0% QoQ

Ownership

0.104%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#89

of 331 holders

Holding Since

Jun 2022

15 quarters on record

Voting authority Sole 16% Shared 0% None 84%

Healthcare · as of Jun 30, 2026

Phocas Financial Corp. holds $23,724,903 across 4 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (11.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	819,476	$14,185,129
2	BCRX	Biocryst Pharmaceuticals Inc	340,541	$3,405,410
3	ELAN	Elanco Animal Health Inc	135,392	$3,331,997
4	SUPN	Supernus Pharmaceuticals, Inc. This page	60,253	$2,802,367

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,802,367	60,253	-5.0%	Shares	Sole	2026-07-31
2026-03-31	$3,277,817	63,413	-22.0%	Shares	Sole	2026-05-01
2025-12-31	$4,041,604	81,320	-20.7%	Shares	Sole	2026-01-26
2025-03-31	$3,358,512	102,550	-5.5%	Shares	Sole	2025-05-09
2024-12-31	$3,922,600	108,479	-0.9%	Shares	Sole	2025-03-05
2024-09-30	$3,412,962	109,460	-5.9%	Shares	Sole	2024-11-07
2024-06-30	$3,112,175	116,343	-1.9%	Shares	Sole	2024-07-24
2024-03-31	$4,043,467	118,542	-2.5%	Shares	Sole	2024-05-01
2023-12-31	$3,517,917	121,559	-22.6%	Shares	Sole	2024-01-30
2023-09-30	$4,330,309	157,066	-0.1%	Shares	Sole	2023-10-10
2023-06-30	$4,725,912	157,216	-0.6%	Shares	Sole	2023-07-13
2023-03-31	$5,727,745	158,094	-9.6%	Shares	Sole	2023-04-13
2022-12-31	$6,240,323	174,946	+31.9%	Shares	Sole	2023-01-11
2022-09-30	$4,488,442	132,598	+25.0%	Shares	Sole	2022-10-14
2022-06-30	$3,068,556	106,105	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.